Delivery Order SPE2DB20D2001-SPE2DB24FM79M

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,585.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMBIEN CR 12.5 MG TABLET 100S, a pharmaceutical product, with a completion date of May 14, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $1,829.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMBIEN CR 12.5 MG TABLET 100S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of January 6, 2025 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp...
This federal contract award, valued at $2,358.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMBIEN CR 12.5 MG TABLET 100S, a prescription sleep medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,926.86 delivery order contract is for the provision of AMBIEN CR 6.25 MG TABLET 100S, a sleep medication. The contract has a firm fixed price pricing type and a completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,299.65, is for the delivery of AMBIEN CR 12.5 MG TABLET 100S, a medication commonly prescribed for the treatment of insomnia. The contract is a Firm Fixed Price Delivery Order with a completion date of January 16, 2025. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside...
This federal contract award is a delivery order with a ceiling value of $2,732.98 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AMBIEN CR 6.25 MG TABLET 100S, a prescription medication, with a performance period through September 24, 2024. This contract is not set aside for any specific business size or socioeconomic category. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,685.42 firm-fixed-price delivery order is for the supply of AMBIEN CR 12.5 MG TABLET 100S, with a completion date of October 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,000.93 firm fixed-price delivery order is for AMBIEN CR 12.5 MG TABLET 100S and has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,439.49 firm fixed-price delivery order is for AMBIEN CR 12.5 MG TABLET 100S and has an ultimate completion date of October 31, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,753.79 delivery order contract is for the supply of AMBIEN CR 6.25 MG TABLET 100S and has a completion date of November 8, 2024. The contract is a firm fixed-price agreement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB24FM79M
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AMBIEN CR 12.5 MG TABLET 100S. The contract has a ceiling value of $4,739.38 and runs through August 13, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. The contract covers the delivery of a specialty medication to federal government facilities, contributing to the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 12:11 PM